the effects of ibopamine , a new orally active dopaminergic agent , on cardiac performance were studied both in a group of healthy volunteers and in a group of patients with congestive heart failure ( chf ) , using non-invasive methods , such as echocardiography and polygraphy .
C0018787
cardiac
C0018802
congestive heart failure